528 related articles for article (PubMed ID: 32056513)
1. DHX9 interacts with APOBEC3B and attenuates the anti-HBV effect of APOBEC3B.
Chen Y; Shen B; Zheng X; Long Q; Xia J; Huang Y; Cai X; Wang D; Chen J; Tang N; Huang A; Hu Y
Emerg Microbes Infect; 2020; 9(1):366-377. PubMed ID: 32056513
[TBL] [Abstract][Full Text] [Related]
2. APOBEC3B edits HBV DNA and inhibits HBV replication during reverse transcription.
Chen Y; Hu J; Cai X; Huang Y; Zhou X; Tu Z; Hu J; Tavis JE; Tang N; Huang A; Hu Y
Antiviral Res; 2018 Jan; 149():16-25. PubMed ID: 29129707
[TBL] [Abstract][Full Text] [Related]
3. Cytidine deaminase APOBEC3B interacts with heterogeneous nuclear ribonucleoprotein K and suppresses hepatitis B virus expression.
Zhang W; Zhang X; Tian C; Wang T; Sarkis PT; Fang Y; Zheng S; Yu XF; Xu R
Cell Microbiol; 2008 Jan; 10(1):112-21. PubMed ID: 17672864
[TBL] [Abstract][Full Text] [Related]
4. Control of APOBEC3B induction and cccDNA decay by NF-κB and miR-138-5p.
Faure-Dupuy S; Riedl T; Rolland M; Hizir Z; Reisinger F; Neuhaus K; Schuehle S; Remouchamps C; Gillet N; Schönung M; Stadler M; Wettengel J; Barnault R; Parent R; Schuster LC; Farhat R; Prokosch S; Leuchtenberger C; Öllinger R; Engleitner T; Rippe K; Rad R; Unger K; Tscharahganeh D; Lipka DB; Protzer U; Durantel D; Lucifora J; Dejardin E; Heikenwälder M
JHEP Rep; 2021 Dec; 3(6):100354. PubMed ID: 34704004
[TBL] [Abstract][Full Text] [Related]
5. Asymmetric Modification of Hepatitis B Virus (HBV) Genomes by an Endogenous Cytidine Deaminase inside HBV Cores Informs a Model of Reverse Transcription.
Nair S; Zlotnick A
J Virol; 2018 May; 92(10):. PubMed ID: 29491156
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus X protein modulates upregulation of DHX9 to promote viral DNA replication.
Shen B; Chen Y; Hu J; Qiao M; Ren J; Hu J; Chen J; Tang N; Huang A; Hu Y
Cell Microbiol; 2020 Mar; 22(3):e13148. PubMed ID: 31829498
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-Inducible Factor 1 Alpha-Mediated RelB/APOBEC3B Down-regulation Allows Hepatitis B Virus Persistence.
Riedl T; Faure-Dupuy S; Rolland M; Schuehle S; Hizir Z; Calderazzo S; Zhuang X; Wettengel J; Lopez MA; Barnault R; Mirakaj V; Prokosch S; Heide D; Leuchtenberger C; Schneider M; Heßling B; Stottmeier B; Wessbecher IM; Schirmacher P; McKeating JA; Protzer U; Durantel D; Lucifora J; Dejardin E; Heikenwalder M
Hepatology; 2021 Oct; 74(4):1766-1781. PubMed ID: 33991110
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA HULC activates HBV by modulating HBx/STAT3/miR-539/APOBEC3B signaling in HBV-related hepatocellular carcinoma.
Liu Y; Feng J; Sun M; Yang G; Yuan H; Wang Y; Bu Y; Zhao M; Zhang S; Zhang X
Cancer Lett; 2019 Jul; 454():158-170. PubMed ID: 30981758
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus X protein-elevated MSL2 modulates hepatitis B virus covalently closed circular DNA by inducing degradation of APOBEC3B to enhance hepatocarcinogenesis.
Gao Y; Feng J; Yang G; Zhang S; Liu Y; Bu Y; Sun M; Zhao M; Chen F; Zhang W; Ye L; Zhang X
Hepatology; 2017 Nov; 66(5):1413-1429. PubMed ID: 28608964
[TBL] [Abstract][Full Text] [Related]
10. Heat shock proteins stimulate APOBEC-3-mediated cytidine deamination in the hepatitis B virus.
Chen Z; Eggerman TL; Bocharov AV; Baranova IN; Vishnyakova TG; Kurlander R; Patterson AP
J Biol Chem; 2017 Aug; 292(32):13459-13479. PubMed ID: 28637869
[TBL] [Abstract][Full Text] [Related]
11. The DNA deaminase APOBEC3B interacts with the cell-cycle protein CDK4 and disrupts CDK4-mediated nuclear import of Cyclin D1.
McCann JL; Klein MM; Leland EM; Law EK; Brown WL; Salamango DJ; Harris RS
J Biol Chem; 2019 Aug; 294(32):12099-12111. PubMed ID: 31217276
[TBL] [Abstract][Full Text] [Related]
12. Effects of point mutations in the cytidine deaminase domains of APOBEC3B on replication and hypermutation of hepatitis B virus in vitro.
Bonvin M; Greeve J
J Gen Virol; 2007 Dec; 88(Pt 12):3270-3274. PubMed ID: 18024895
[TBL] [Abstract][Full Text] [Related]
13. Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication.
Bonvin M; Achermann F; Greeve I; Stroka D; Keogh A; Inderbitzin D; Candinas D; Sommer P; Wain-Hobson S; Vartanian JP; Greeve J
Hepatology; 2006 Jun; 43(6):1364-74. PubMed ID: 16729314
[TBL] [Abstract][Full Text] [Related]
14. A Conserved Mechanism of APOBEC3 Relocalization by Herpesviral Ribonucleotide Reductase Large Subunits.
Cheng AZ; Moraes SN; Attarian C; Yockteng-Melgar J; Jarvis MC; Biolatti M; Galitska G; Dell'Oste V; Frappier L; Bierle CJ; Rice SA; Harris RS
J Virol; 2019 Dec; 93(23):. PubMed ID: 31534038
[TBL] [Abstract][Full Text] [Related]
15. Human APOBEC3B interacts with the heterogenous nuclear ribonucleoprotein A3 in cancer cells.
Mishra N; Reddy KS; Timilsina U; Gaur D; Gaur R
J Cell Biochem; 2018 Aug; 119(8):6695-6703. PubMed ID: 29693745
[TBL] [Abstract][Full Text] [Related]
16. DDX3 DEAD-box RNA helicase is a host factor that restricts hepatitis B virus replication at the transcriptional level.
Ko C; Lee S; Windisch MP; Ryu WS
J Virol; 2014 Dec; 88(23):13689-98. PubMed ID: 25231298
[TBL] [Abstract][Full Text] [Related]
17. NTCP-Reconstituted In Vitro HBV Infection System.
Sun Y; Qi Y; Peng B; Li W
Methods Mol Biol; 2017; 1540():1-14. PubMed ID: 27975303
[TBL] [Abstract][Full Text] [Related]
18. Evidence of associations of APOBEC3B gene deletion with susceptibility to persistent HBV infection and hepatocellular carcinoma.
Zhang T; Cai J; Chang J; Yu D; Wu C; Yan T; Zhai K; Bi X; Zhao H; Xu J; Tan W; Qu C; Lin D
Hum Mol Genet; 2013 Mar; 22(6):1262-9. PubMed ID: 23213177
[TBL] [Abstract][Full Text] [Related]
19. RNA Helicase DDX17 Inhibits Hepatitis B Virus Replication by Blocking Viral Pregenomic RNA Encapsidation.
Mao R; Dong M; Shen Z; Zhang H; Liu Y; Cai D; Mitra B; Zhang J; Guo H
J Virol; 2021 Sep; 95(19):e0044421. PubMed ID: 34287051
[TBL] [Abstract][Full Text] [Related]
20. 5'-triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells.
Chen X; Qian Y; Yan F; Tu J; Yang X; Xing Y; Chen Z
Eur J Pharmacol; 2013 Dec; 721(1-3):86-95. PubMed ID: 24099962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]